Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL

ASCO 2020 Virtual Meeting/May 29-31, 2020
EHA 2020 Virtual Meeting/June 11-21, 2020
Listen to Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss the implications of recent trial results in CLL presented at the 2020 annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA).
John Allan, MD
Jennifer R. Brown, MD, PhD
Released: August 26, 2020

In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in CLL presented at the 2020 annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA). Studies and topics include:

  • ASCEND: acalabrutinib vs idelalisib plus rituximab or BR
  • ACE-CL-001: acalabrutinib long-term efficacy
  • CLL14: Venetoclax plus obinutuzumab
  • CLARITY: Ibrutinib plus venetoclax
  • Measurable residual disease (MRD)
  • Complex karyotypes
  • Zanubrutinib plus obinutuzumab and venetoclax

Content based on an online CME program supported by an educational grant from AstraZeneca.

Link to full program: https://www.clinicaloptions.com/oncology/conference-coverage/global-asco-eha-2020

Acknowledgements

Supported by an educational grant from
AstraZeneca

Related Content

A downloadable slideset from Clinical Care Options (CCO) developed by expert faculty on the proper diagnosis and management of aTTP using the latest clinical guidelines

Paul Coppo, MD, PhD Released: December 8, 2021

CCO Conference Coverage of ASH 2021 with downloadable slides and experts’ commentaries of clinically relevant studies

John M. Burke, MD Amy E. DeZern, MD, MHS Shaji K. Kumar, MD Sagar Lonial, MD Peter Martin, MD Mark A. Schroeder, MD Sujit Sheth, MD B Douglas Smith B. Douglas Smith, MD Srdan Verstovsek, MD, PhD Eunice S. Wang, MD Released: December 8, 2021

Commentary from Dr. Julie Vose on how to select therapy for patients with EBV-positive PTLD, from Clinical Care Options (CCO)

Julie M. Vose, MD, MBA Released: December 6, 2021

Downloadable PDF resource guide with key information and resources for optimal management of patients with T-cell lymphomas, from clinical care options (CCO)

Talha Khan, PharmD, BCOP Released: December 6, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue